当前位置:首页 - 行情中心 - XD上海医(601607) - 财务分析 - 现金流量表

XD上海医

(601607)

  

流通市值:443.48亿  总市值:589.63亿
流通股本:27.89亿   总股本:37.08亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金154,053,366,202.374,380,745,244.37310,476,389,933.39223,734,692,550.11
  收到的税费返还109,855,354.6451,627,668.16215,861,045.48152,560,975.79
  收到其他与经营活动有关的现金2,556,708,318.271,206,887,070.233,071,842,865.883,582,188,850.87
  经营活动现金流入小计156,719,929,875.2175,639,259,982.76313,764,093,844.75227,469,442,376.77
  购买商品、接受劳务支付的现金135,698,209,949.9466,948,554,202.12277,210,199,143.72199,383,937,006.94
  支付给职工以及为职工支付的现金5,831,131,741.992,849,976,624.7811,384,470,428.27,293,925,442.42
  支付的各项税费4,363,036,457.172,246,061,589.517,699,771,165.265,827,774,466.5
  支付其他与经营活动有关的现金6,378,042,478.014,604,361,940.4811,315,451,728.212,613,995,295.32
  经营活动现金流出小计152,270,420,627.1176,648,954,356.89307,609,892,465.38225,119,632,211.18
  经营活动产生的现金流量净额4,449,509,248.1-1,009,694,374.136,154,201,379.372,349,810,165.59
二、投资活动产生的现金流量:
  收回投资收到的现金25,040,393,817.516,602,451,639.0664,905,208,473.3750,949,303,686.76
  取得投资收益收到的现金113,641,41614,243,328.17533,339,309.47366,774,426.61
  处置固定资产、无形资产和其他长期资产收回的现金净额171,004,797.66106,338,795.63105,146,870.8579,911,584.05
  处置子公司及其他营业单位收到的现金净额2,617,197.942,617,197.9440,221,651.2424,108,575.12
  收到的其他与投资活动有关的现金1,342,676,726.4960,000,0001,435,611,552.971,388,824,800
  投资活动现金流入小计26,670,333,955.66,785,650,960.867,019,527,857.952,808,923,072.54
  购建固定资产、无形资产和其他长期资产支付的现金1,040,988,005.6687,114,232.512,325,878,841.631,612,196,921.12
  投资支付的现金23,805,749,556.726,315,309,056.7266,832,506,032.9149,914,249,000
  取得子公司及其他营业单位支付的现金--280,306,149.16656,284,741
  支付其他与投资活动有关的现金1,430,000,00070,000,0001,563,066,489.91,416,500,364.13
  投资活动现金流出小计26,276,737,562.327,072,423,289.2371,001,757,513.653,599,231,026.25
  投资活动产生的现金流量净额393,596,393.28-286,772,328.43-3,982,229,655.7-790,307,953.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金392,000,000-23,928,175.77,378,175.7
  其中:子公司吸收少数股东投资收到的现金392,000,000-16,550,000-
  取得借款收到的现金32,255,426,049.5420,209,326,091.7661,326,650,569.9148,090,270,678.15
  发行债券收到的现金5,999,628,055.562,999,852,5007,997,083,333.337,997,083,333.33
  收到其他与筹资活动有关的现金30,310,263.9382,501,000220,182,772.32198,437,899.47
  筹资活动现金流入小计38,677,364,369.0323,291,679,591.7669,567,844,851.2656,293,170,086.65
  偿还债务支付的现金37,835,602,901.0822,124,665,813.9470,215,579,438.4552,938,358,758.11
  分配股利、利润或偿付利息支付的现金1,386,699,569.06830,241,941.483,851,752,338.093,133,071,878.37
  其中:子公司支付给少数股东的股利、利润393,103,543.05155,045,608.191,051,801,460.89758,979,753.81
  支付其他与筹资活动有关的现金403,451,945.49184,430,354.991,152,281,453.3775,374,455.43
  筹资活动现金流出小计39,625,754,415.6323,139,338,110.4175,219,613,229.8456,846,805,091.91
  筹资活动产生的现金流量净额-948,390,046.6152,341,481.35-5,651,768,378.58-553,635,005.26
四、汇率变动对现金及现金等价物的影响-8,971,209.55-8,778,258.86-3,115,599.14-11,454,659.07
五、现金及现金等价物净增加额3,885,744,385.23-1,152,903,480.07-3,482,912,254.05994,412,547.55
  加:期初现金及现金等价物余额28,398,360,540.8228,398,360,540.8231,881,272,794.8731,881,272,794.87
  期末现金及现金等价物余额32,284,104,926.0527,245,457,060.7528,398,360,540.8232,875,685,342.42
补充资料:
  净利润4,341,656,313.04-6,973,717,681.49-
  资产减值准备28,045,168.32-1,018,555,938.73-
  固定资产和投资性房地产折旧754,363,642.25-1,512,910,120.05-
  无形资产摊销324,159,569.06-602,493,205.87-
  长期待摊费用摊销84,318,125.33-198,488,749.61-
  处置固定资产、无形资产和其他长期资产的损失-179,699,818.59--157,152,717.09-
  公允价值变动损失-1,951,396.44--332,120,868.45-
  财务费用692,661,912.58-1,669,610,270.78-
  投资损失-921,381,409.6--3,409,098,249.27-
  递延所得税-185,338,212.82-572,259,675.46-
  其中:递延所得税资产减少-224,320,335.41-37,097,310.92-
    递延所得税负债增加38,982,122.59-535,162,364.54-
  存货的减少2,635,897,136.23--5,196,581,328.95-
  经营性应收项目的减少-6,504,749,025.29--3,668,534,969.05-
  经营性应付项目的增加2,517,684,376.96-5,048,228,397.42-
  现金的期末余额32,284,104,926.05-28,398,360,540.82-
  减:现金的期初余额28,398,360,540.82-31,881,272,794.87-
  现金及现金等价物的净增加额3,885,744,385.23--3,482,912,254.05-
公告日期2026-08-282026-04-302026-03-312025-10-31
审计意见(境内)标准无保留意见
TOP↑